Richard Kollmar, PhD, is an Associate Professor in the Department of Cell Biology at SUNY Downstate Medical Center . His research focuses on molecular genetics of otolith formation in zebrafish and regeneration of spiral ganglion neurons in mice . He combines proteomics, molecular biology, and embryology to study biomineralization and Wnt-Frizzled signaling pathways. Research Interests : Molecular mechanisms of inner ear morphogenesis and regeneration Cross-species proteomics and genetic networks in otolith development Wnt signaling in auditory neuron repair and cochlear implants Publications : 15+ studies on zebrafish otolith proteins (e.g., Sparc) and neuronal regeneration Recent work on neurocritical care milestones and contrast-induced encephalopathy Labs & Teams : Established culture protocols for adult spiral ganglion neurons Collaborates on clinical trials like INTREPID and WAKE-UP
Pernilla Videhult Pierre is a Lecturer at the Department of Clinical Science, Intervention and Technology, Karolinska Institutet, working within the Division of Audiology. Her research focuses on understanding and mitigating drug-induced hearing loss while developing protective strategies against auditory damage. Education: PhD in Oncology-Pathology, Karolinska Institutet (2010) Research interests span three main areas: Medicinal Chemistry - Investigating platinum-based chemotherapeutic agents and protective sulfur-containing compounds Otoprotection - Developing hydrogen gas therapy and polymer-based delivery systems to prevent auditory damage Auditory Metabolomics - Using LC-MS techniques to analyze cochlear fluid changes under different treatments Publication trends show a consistent focus on auditory protection mechanisms, particularly against cisplatin-induced ototoxicity. Key methodologies include guinea pig models, hydrogen therapy applications, and advanced chromatographic techniques. Her work bridges pharmaceutical sciences with clinical audiology applications.
Bryan C. Bjork, Ph.D. is an Associate Professor of Biochemistry and Molecular Genetics at Midwestern University with cross-appointments in the Chicago College of Optometry, College of Graduate Studies, College of Health Sciences-Downers Grove, and College of Dental Medicine-Illinois. He has been at Midwestern University since 2011, earning tenure in 2017 and promotion to Associate Professor in 2018. Dr. Bjork's educational background includes: Ph.D. in Biochemistry from the University of Iowa (2001) B.A. from Augustana College (IL) (1994) Postdoctoral Fellowship in Genetics at Brigham & Women's Hospital/Harvard Medical School (2001-2011) His research program focuses on the etiology of human and mouse craniofacial birth defects, with particular emphasis on developmental and molecular characterization of cleft palate in mouse mutants for transcription factors Prdm16 and Mecom. Dr. Bjork utilizes advanced techniques including mouse mutagenesis, uCT scanning for morphometric analysis of craniofacial structures, and CRISPR-Cas9 technology. His work bridges basic science with clinical applications, investigating how genetic mutations lead to congenital anomalies in craniofacial and ear development. He collaborates with researchers in Anatomy to study inner and middle ear defects and cranial bone variations. Dr. Bjork's publication record demonstrates a consistent focus on developmental genetics and craniofacial biology, with recent work examining PRDM16's role in cochlear development and neural progenitor progression. His earlier publications also include significant contributions to interprofessional education, developing innovative approaches to improve collaboration between future healthcare professionals. Dr. Bjork actively mentors students across multiple programs including the Master of Arts in Biomedical Sciences (M.A.) and Master of Biomedical Sciences (M.B.S.) programs. His research is supported by Midwestern University intramural funding, specifically the grant "Prdm16 and Prdm3 Functions in Mouse Embryonic Craniofacial Cartilage and Bone Development Impact Normal Mandible and Palate Development." He teaches a wide range of biochemistry and genetics courses across Midwestern University's health science programs, including for Physician Assistant, Biomedical Sciences, Precision Medicine, Pharmacy, Osteopathic Medicine, and Dental Medicine students. His teaching philosophy emphasizes critical thinking and interprofessional collaboration.
Prof. David Keays serves as Chair of Organismal and Developmental Neurobiology within the Faculty of Biology at Ludwig Maximilian University of Munich (LMU). He leads the Keays Lab, a core component of the Munich Center for Neurosciences (MCN) and Graduate School of Systemic Neurosciences (GSN), where he also holds a Scientific Board position. His research integrates advanced methodologies including 2-photon imaging, electrophysiology, and CRISPR/Cas9 genome editing to address fundamental questions in sensory and developmental neuroscience. Keays' research focuses on three interconnected domains: the biophysical mechanisms of animal magnetoreception, the role of microtubule mutations in neurodevelopmental disorders, and the evolutionary neurobiology of monotremes. His lab employs reductionist experimental approaches to investigate how magnetic fields are detected, how tubulin mutations disrupt neuronal migration, and why egg-laying mammals possess unique neural architectures. This work spans molecular genetics, cellular imaging, and comparative neuroanatomy. Analysis of Keays' recent publications (2019-2025) reveals dominant research trajectories in avian magnetoreception mechanisms and tubulin-related neuropathologies. Key themes include cryptochrome protein function, iron-based magnetic sensing structures, and the developmental consequences of tubulin mutations. His work bridges quantum biology, clinical neurology, and evolutionary neuroscience, demonstrating consistent innovation in both conceptual frameworks and technical methodologies. Scientific awards and honors are not documented in the available source materials. Keays mentors doctoral candidates including Patrick Heisterkamp, Carolina Duro, Alexandra Vilceanu, and Thamari Kapuruge. His research program receives competitive funding, though specific grant details are not provided in the source texts. The lab actively contributes to graduate training through the GSN and maintains rigorous standards for data integrity and publication ethics. The Keays Lab operates within LMU's Neurobiology department, maintaining specialized facilities for 2-photon imaging, single-cell sequencing, and transgenic model development. The team collaborates extensively with MCN and GSN affiliates, utilizing cerebral organoid systems and quantum magnetic imaging to advance understanding of sensory processing and neurodevelopment. Current infrastructure supports high-resolution in vivo imaging and molecular manipulation of neural circuits.
Inna Hughes, M.D., Ph.D., serves as Associate Professor of Child Neurology and Epilepsy at the University of Rochester School of Medicine and Dentistry, holding primary appointments in the Department of Neurology and a joint appointment in Pediatrics. Board-certified in Neurology with Special Qualification in Child Neurology and Epilepsy, she practices at UR Medicine's Epilepsy Center and Golisano Children's Hospital, where she provides comprehensive care for pediatric neurological conditions. Her educational trajectory includes undergraduate studies at Williams College (Magna cum Laude in Biology, 1999), followed by a combined MD/PhD program at Washington University School of Medicine (2007). Clinical training encompassed Pediatrics internship (2007-2009), Child Neurology residency (2009-2012), and Pediatric Epilepsy fellowship (2014-2015), all completed at the University of Rochester Medical Center. Dr. Hughes' research program centers on pediatric epilepsy, with specific emphasis on genetic mechanisms of childhood-onset epilepsy syndromes, dietary interventions for seizure management, and transitional care models for adolescents moving to adult epilepsy services. Her work extends to community education initiatives aimed at improving epilepsy awareness and patient self-management strategies, reflecting a commitment to both clinical innovation and public health impact. Analysis of her publication record reveals two distinct research phases: contemporary work (2018-2025) focuses on clinical epilepsy care quality improvement and genetic epilepsy mechanisms, while earlier publications (2004-2011) stem from her doctoral training in inner ear development and otopetrin gene function, demonstrating interdisciplinary expertise spanning molecular biology and clinical neurology. Her scientific recognition includes: Alpha Omega Alpha Society membership (2011) Spencer T and Ann W. Olin Medical Scientist Fellowship (2007) Ruth L. Kirschstein National Research Service Award (2004-2007) Multiple travel awards and departmental honors during graduate training Supported by significant research funding including NIH Kirschstein Fellowships and Medical Scientist Training Program grants, Dr. Hughes contributes to national quality improvement initiatives through the American Epilepsy Society. Her clinical practice at the Epilepsy Center involves multidisciplinary collaboration with neurosurgeons, neuropsychologists, and specialized nursing staff to deliver integrated care for complex pediatric seizure disorders.
Andreas Heyd is a Researcher and IT Manager at the University of Tübingen, affiliated with the Tübingen Hearing Research Center and the Department of Otolaryngology. His work focuses on inner ear physiology and the development of fully implantable hearing devices, combining technical expertise in computer network maintenance with contributions to medical research. Research Interests: His research bridges biomedical engineering and auditory neuroscience, targeting the physiological mechanisms of hearing and innovative medical device design. Contact: Email: andreas.heyd@uni-tuebingen.de
Dr. Orhan Beger is an Associate Professor in the Department of Basic Medical Sciences at Gaziantep University Faculty of Medicine. He specializes in human anatomy with particular focus on neuroanatomy, skull anatomy, and fetal development. His academic journey includes a Doctorate in Anatomy from Mersin University (2014-2019) and a Veterinary Medicine degree from Istanbul University (2005-2010). His educational background includes: Doctorate in Anatomy, Mersin University Institute of Health Sciences (2014-2019) Licence in Veterinary Medicine, Istanbul University Faculty of Veterinary Medicine (2005-2010) Dr. Beger's research interests center around anatomical studies with clinical applications, particularly in the areas of: Neuroanatomy and skull base morphology Chiari malformation anatomical studies Fetal and pediatric anatomical development Radiological anatomy Temporal bone and ear anatomy His work bridges basic anatomical science with clinical applications in neurosurgery, otolaryngology, and pediatric medicine. Dr. Beger has contributed significantly to the field through numerous publications, with over 100 articles in SCI-indexed journals. His recent work focuses on anatomical variations in pediatric populations, particularly related to skull base structures and their implications for surgical approaches. His research demonstrates a consistent pattern of investigating anatomical structures through both cadaveric and radiological methods, with emphasis on clinical relevance. His scientific achievements include: 2020 University Certificate of Appreciation 2018 Civil Society Organization Oral Presentation First Prize 2017 Civil Society Organization Atilla Müftüoğlu Young Researcher Award Dr. Beger has supervised six master's theses, guiding students through research on pediatric anatomy, facial morphometry, and fetal musculoskeletal development. He has also led research projects focused on cadaver preservation techniques and facial plastic surgery applications. His teaching responsibilities include anatomy courses for both Turkish and English-medium medical programs. He serves as the Domestic Education Coordinator at Gaziantep University and has completed specialized training in animal experimentation, educational skills, and cadaver fixation techniques.
John A. Germiller, MD, PhD, serves as Professor of Clinical Otorhinolaryngology: Head and Neck Surgery at the Perelman School of Medicine, University of Pennsylvania, and as Attending Surgeon and Director of Clinical Research in the Division of Otolaryngology (ENT) at Children's Hospital of Philadelphia (CHOP). His clinical practice focuses on pediatric otolaryngology with specialization in cochlear implantation and pediatric ear disorders. Education: PhD in Biomedical Engineering - University of Michigan, Ann Arbor MS in Biomedical Engineering - University of Michigan, Ann Arbor MD - University of Michigan, Ann Arbor (Graduation with Distinction and Research) General Surgery Internship - University of Michigan Hospitals Otolaryngology-Head & Neck Surgery Residency - University of Michigan Pediatric Otolaryngology Fellowship - Children's Hospital of Philadelphia Research Focus: Dr. Germiller's research encompasses hearing loss in children , with particular emphasis on inner ear and auditory nerve development , genetics of hearing disorders , and congenital ear abnormalities . His work bridges clinical practice with translational research, developing innovative approaches to pediatric hearing restoration including novel cochlear implantation techniques and regenerative therapies for tympanic membrane repair. Scientific Contributions: His recent publications demonstrate a multidisciplinary approach combining surgical outcomes research with molecular genetics and clinical trials. A notable trend is his focus on pediatric-specific challenges in otolaryngology, including pain management after tonsillectomy, cochlear implantation in special populations, and the development of clinical data repositories for pediatric hearing research. Awards & Recognition: 2022 SPROUT Program Award for innovative pediatric tympanoplasty research 2022 NEMO Prize finalist for translational medical engineering 2018 Honors Award from American Academy of Otolaryngology-Head & Neck Surgery Foundation Multiple early career awards including New Investigator Award and Otologic Research Awards Election to Alpha Omega Alpha Medical Honor Society Professional Leadership: Dr. Germiller serves as permanent member of CHOP's Institutional Review Board and participates in numerous selection committees for residency and fellowship programs. He is actively involved in national organizations including ASPO, ARO, and AAO-HNS, contributing to editorial boards and peer review for leading otolaryngology journals. Team Affiliations: He collaborates with CHOP's Hearing Implant Program , Center for CdLS and Related Diagnoses , and Clinical In Vivo Gene Therapy initiatives, leading multidisciplinary teams in advancing pediatric otolaryngology care and research.
Dr. Robert Knight is a Reader in Developmental Genetics at King’s College London, affiliated with the Centre for Craniofacial & Regenerative Biology and Faculty of Dentistry, Oral & Craniofacial Sciences. He obtained his PhD in Molecular Evolution from the University of Reading in 2000, followed by postdoctoral work at UC Irvine and University of Sheffield, focusing on AP-2 genes, neural crest, and cranial muscle development in zebrafish. His research explores molecular regulation of muscle regeneration and stem cell behavior, combining live imaging, transcriptomics, and zebrafish models. Key findings include the role of Ret tyrosine kinase in facial muscle development and FSHD therapy, RhoA coupling migration/differentiation, and NF-κB in macrophage function during repair. Collaborations span systems biology (Dresden), physiology (Amsterdam), and macrophage signaling (Lyon). Recent publications highlight trends in muscle stem cell dynamics , signaling pathways (Wnt, Notch, Ret), and age-related regeneration . His work aligns with SDGs via health (musculoskeletal diseases) and innovation (AI in biosciences, multiphoton microscopy). Scientific Awards: BBSRC Project Award MDUK Studentship NC3Rs Studentship Royal Society Partnership Award Carl Zeiss Collaboration Current projects address DUX4-activated Ret in FSHD, chromatin organization in aging, and macrophage-stem cell interactions . He leads grants from BBSRC, Dunhill Medical Trust, and Leverhulme Trust.
Maarja Haugas is a Research Fellow at the University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine. She also serves as a Specialist at Tartu University Hospital's Genetics and Personalized Medicine Clinic. Her career spans institutions including University of Helsinki and Quattromed AS, with research focusing on biomedical applications, cancer biology, and developmental neuroscience. Doctor's Degree (2011), University of Helsinki: GATA Factors Regulate Inner Ear Development and Midbrain Neurogenesis Research Master's Degree (2005), University of Tartu: Gata3 Regulates Placode Morphogenesis and Fgf Signaling Her research interests integrate Biomedicine , Clinical Biology , and Precision Medicine , with specific expertise in GATA transcription factors , neuronal differentiation , and targeted peptide therapies . Recent publications demonstrate innovation in tumor-targeting peptides, CAR T-cell engineering, and mitochondrial DNA regulation. 2025: Cyclic peptide glioblastoma targeting via SNAP25 2024: Protease-activated CendR peptides for tumor specificity 2023: β1-integrin aptamers for breast cancer therapy Scientific honors include the 2015 Tartu University Development Fund Award , 2013 University of Helsinki Postdoctoral Position , and 2006 Marie Curie Fellowship . She contributes to the Estonian Society of Medical Genetics since 2024, with administrative experience in R&D settings. Her work bridges developmental biology, cancer research, and translational medicine through molecular mechanisms and targeted delivery systems.
Douglas Houston is a Professor in the Department of Biology at the University of Iowa, where he also serves as Director of the Developmental Studies Hybridoma Bank (DSHB). He holds a PhD from the University of Miami. His research investigates vertebrate developmental mechanisms, with a focus on maternal signaling pathways, RNA localization, and cytoskeletal dynamics in Xenopus models. Key areas include cortical rotation, Wnt signaling activation, and the role of asymmetrically localized mRNAs in embryonic axis formation. His work spans Cell and Developmental Biology and Neurobiology , emphasizing molecular regulation of early embryogenesis. Research integrates genetic, biochemical, and imaging approaches to dissect mechanisms of dorsal axis specification and neural development. Recent studies explore antibody validation protocols to enhance biomedical research reproducibility. Houston directs the DSHB, a core facility supporting antibody-based research globally. The lab employs Xenopus laevis and Xenopus tropicalis for functional genomics, including CRISPR-based editing and maternal mRNA manipulation techniques.
Jaime Garcia-Anoveros, PhD is a Professor at Northwestern University's Feinberg School of Medicine with joint appointments in Anesthesiology, Neuroscience, and the Ken and Ruth Davee Department of Neurology. His research spans multiple interdisciplinary centers including the Center for Genetic Medicine, Center for Translational Pain Research, Denning Ataxia Center, Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders, Northwestern University Clinical and Translational Sciences Institute (NUCATS), Simpson Querrey Institute for Epigenetics, and Skin Biology and Diseases Resource-Based Center. Dr. Garcia-Anoveros earned his BS from UC Berkeley (1989), MA from Columbia University College of Physicians and Surgeons (1990), MPhil from Columbia University (1992), and PhD from Columbia University (1995). He completed postdoctoral training at Harvard Medical School and Massachusetts General Hospital in the Departments of Neurobiology and Neurology under David P. Corey. His primary research focuses on the development of cochlear outer versus inner hair cells, auditory nociception (pain pathways in the ear), hyperacusis, hair cell degeneration and hearing loss, sensory organ development and degeneration, and specialized lysosomes in hair cells and neonatal enterocytes. His groundbreaking work has identified a novel pain pathway in the inner ear that acts as a "bodyguard" against hearing loss from loud noises and demonstrated how lysosomal dysfunction contributes to infant failure to thrive. Dr. Garcia-Anoveros serves as a Permanent Member of the NIH AUD (Auditory System) study section (2020-present) and on the Editorial Board of F1000 Research (2012-present). His work has been published in top journals including Nature, Science Advances, Nature Communications, and PLOS Genetics. Bellucci Pioneer Award in Hearing Research, Bellucci Translational Hearing Center at Creighton University (2023) As a principal investigator, Dr. Garcia-Anoveros has secured significant research funding from the National Institutes of Health, including grants from the National Institute of Deafness and Other Communication Disorders and National Institute of Neurological Disorders and Stroke. He is an active member of the Society for Developmental Biology, Association for Research in Otolaryngology, and Society for Neuroscience. His laboratory focuses on understanding the genetic and molecular mechanisms underlying hearing development and disorders, with particular emphasis on TRPML3 channels and their role in sensory cells. Current research directions include developing tools for creating hearing cells lost in aging and understanding the logic circuit in cochlear neurodevelopment.
Zheng-Yi Chen is an Associate Professor of Otolaryngology Head and Neck Surgery at Harvard Medical School, affiliated with the Eaton-Peabody Laboratories at Massachusetts Eye and Ear Infirmary in Boston. His research focuses on developing therapies for hearing loss, including genetic, noise-induced, and age-related forms. Key areas include gene therapy, hair cell regeneration, and clinical translation of auditory neuroscience discoveries. Laboratory Website: Eaton-Peabody Laboratories Email: zheng-yi_chen@meei.harvard.edu Research Highlights Conducted the first successful clinical trial of OTOF gene therapy, restoring hearing in children with DFNB9 deafness. Developed gene editing treatments for genetic deafness in preclinical studies. Discovered FDA-approved drugs for noise-induced hearing loss protection. Investigated molecules promoting spiral ganglion neurofiber outgrowth for synaptopathy treatment. Created human inner ear organoids for disease modeling and drug screening. Technological Innovations Adult cochlea explant culture Innovative inner ear delivery systems
David Paul Corey serves as the Bertarelli Professor of Translational Medical Science at Harvard Medical School's Department of Neurobiology. His research focuses on mechanotransduction in vertebrate hair cells, particularly the structural and functional analysis of tip-link proteins (CDH23, PCDH15) and transduction channels (TMC1/2). The Corey Laboratory develops gene therapies for Usher syndrome and hereditary deafness using advanced techniques including X-ray crystallography Single-molecule force spectroscopy Adeno-associated viral vectors Cryo-electron microscopy Current translational work targets Usher syndrome type 1F through dual-AAV delivery systems and base editing approaches. The lab employs multidisciplinary methods combining biophysics , molecular genetics , and nanomechanical modeling to understand and treat sensory deficits. Recent publications highlight breakthroughs in Mini-PCDH15 protein design Primate gene therapy safety Transduction channel pore characterization Therapeutic force spectroscopy with ongoing clinical translation efforts. Scientific distinctions include: Bertarelli Foundation Professorship NIH grant collaborations Leadership in mechanotransduction
Professor Dennis M Freeman is a faculty member at the School of Engineering , Massachusetts Institute of Technology , where he holds a joint appointment in the Department of Electrical Engineering and Computer Science . His research focuses on understanding the cellular and molecular mechanisms of human hearing , particularly through studying the tectorial membrane and its role in auditory sensitivity and selectivity. Discovered tectorial membrane wave dynamics' contribution to hearing properties Developed motion microscopy for nanoscale motion analysis Investigated age-related CEACAM16 loss effects on auditory function His work addresses critical gaps in hearing remediation by targeting fundamental auditory mechanics rather than symptomatic treatments.
